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Rossetti et al. used a dominant-negative form of CaMKII to erase a hippocampaldependent behavioral memory. Taken together with other results, the new findings make the strong case that memory storage is mediated by CaMKII.
INTRODUCTION
The molecular mechanisms by which memories are stored remain one of the major unsolved problems in neuroscience (Mayford et al., 2012) . Long-term potentiation (LTP), an activity-dependent strengthening of synapses, is a candidate memory mechanism (Bliss and Collingridge, 2013; Morris et al., 2003) , and there have therefore been major efforts to understand the underlying molecular mechanisms, with the CA1 region of the hippocampus being the major model system. In CA1, LTP is initiated by the opening of NMDA channels; the resulting influx of Ca 2+ activates a CaMKII-dependent cascade that leads to the addition of AMPA channels to the postsynaptic membrane (Nicoll, 2017) .
Although LTP is a strong candidate as a memory mechanism, it has been difficult to provide definitive evidence for its central role. Notably, LTP is very difficult to observe and manipulate during actual learning experiments. Thus, the most direct tests of the memory function of any putative memory molecule are by behavioral experiments that examine how perturbations of the molecule affect memory itself. In previous behavioral experiments, knockin of the T286A mutation of CaMKII-alpha, a mutant that prevents persistent activation of the enzyme by brief elevation of Ca 2+ (Miller and Kennedy, 1986; Saitoh and Schwartz, 1985) , or expression of a dominant-negative CaMKII (catalytically dead; K42M or K42R) strongly reduced hippocampaldependent learning and memory (Giese et al., 1998; Yamagata et al., 2009) . These results establish a critical role of CaMKII in memory processes, but leave open the question of whether CaMKII initiates the information storage process that underlies long-term memory or whether CaMKII mediates the storage process itself (or does both). A specific test of the role of a molecule in memory storage (maintenance) is the erasure test (Pastalkova et al., 2006) . In this test, learning of a behavioral task occurs under normal conditions. Then, an inhibitor of a putative memory molecule is introduced, with the critical question being whether this inhibits recall of the memory. If such inhibition occurs, it cannot be due to an effect on learning because the inhibitory substance was not present at the time of learning. Positive results, however, do not necessarily implicate the storage process because expression (recall) processes might be inhibited. Removal of inhibitor prior to recall can clarify this issue. If the inhibitor affected an expression process, recall will be successful if memory is tested after the inhibitor is removed. In contrast, if the inhibitor erased a storage process, subsequent recall will not be successful.
Recent work using the erasure test suggests that CaMKII has a key role in the storage process that underlies the maintenance of LTP. Specifically, transient application of a CaMKII inhibitor produced persistent reversal of saturated LTP, making it then possible to reinduce LTP (Barcomb et al., 2016; Gouet et al., 2012; Sanhueza et al., 2011) . Thus, it has been of special interest to test the role of CaMKII in the storage of behaviorally defined memory. Two previous studies have sought to conduct such tests. Experiments on the accumbens indicate that addictive behavior can be erased by transient expression of a dominant-negative CaMKII (Loweth et al., 2013) . In contrast, experiments on amygdaladependent fear conditioning showed that a photoactivatable CaMKII inhibitor could interfere with learning, but could not erase a previously established memory (Murakoshi et al., 2017) . Thus, the importance of CaMKII in memory storage remains unclear. Here, we conducted two behavioral experiments that probe the role of CaMKII in the storage of hippocampal-dependent memory, the form that has been the focus of physiological and behavioral experiments aimed at elucidating the mechanisms of episodic memory.
RESULTS
As a basis for using herpes simplex virus (HSV) to determine whether dominant-negative CaMKII could erase memory, we first did control experiments with virally delivered GFP. To assay memory, we used a conditioned place-avoidance task, a task that depends on the hippocampus (Pastalkova et al., 2006) . A rat was placed on a rotating platform that would eventually bring the rat into a shock zone, a region defined by its fixed relationship to visual cues on the wall ( Figure 1A ). Over the course of twelve 10-min trials (one set of 6 on day 1 and another set of 6 on day 4), rats learned to avoid the shock zone. The number of shocks per trial was used as a measure of memory; the average number of shocks per trial fell from $15 in trial 1 to $1 in trial 12 ( Figures  3A and 3C ). On day 7, 3 days after the end of training, virus injections were made bilaterally (eight total; see Figure 1 legend and STAR Methods). GFP expression was evident 3 days after injection (day 10) ( Figure 1B ). Using a neuronal selective antibody (NeuN), expression was determined to have occurred in 35%-50% of neurons within the transfected regions near the injection sites ( Figure 1C ). Memory retention on day 16 was excellent for these rats ( Figures 3A and 3C) ; the average number of shocks per trial was approximately two, statistically the same (p = 0.98, D = 0.33) as the first retention trial (trial 13) in another group of animals on day 10 ( Figures 4A and 4C ) or the last trial (trial 12) before viral injection (p = 0.81, D = 0.33). We conclude that memory was not erased by viral expression of GFP.
As noted earlier, proper implementation of the erasure test requires that expression of inhibitor (e.g., dominant-negative CaMKII) be transient. HSV was chosen as a delivery system because it has the property of producing only transient (severalday) expression (Carlezon et al., 1997; Neve et al., 2005) . We confirmed transient expression: CaMKII T286D/T305A/T306A-GFP or GFP were present on day 10 but absent on day 16 (Figure 1B ), the day we tested for erasure (see below). Because we co-injected fluorescent beads with virus, we could use their presence (see red beads in Figure 1B , bottom panels) to verify that injections had been successful even when virally expressed protein was no longer present.
To determine whether memory could be erased, we injected HSV that expressed the widely utilized dominant-negative mutant form of CaMKII (K42M) (K€ uhl et al., 2000; Xiao et al., 2005; Yamagata et al., 2009 ). This kinase-dead mutant can translocate to synapses during strong synaptic stimulation and undergo binding to postsynaptic density (PSD) proteins (Barcomb et al., 2013; Bayer et al., 2001; Jiao et al., 2011; O'Leary et al., 2011; Shen and Meyer, 1999) but has weaker than normal binding to the NMDAR. Specifically, biochemical analysis shows that weak binding arises because some of the binding sites involved require phosphorylation of T286 (Bayer et al., 2001) , which is reduced in the kinase-dead mutant. Furthermore, the mutation reduces the ATP binding that contributes to the CaMKII/NMDAR interaction (O'Leary et al., 2011) . Previous biochemical work on this dominant-negative mutation showed that it reduced basal phosphorylation of CaMKII (Loweth et al., 2013; Yamagata et al., 2009) . In physiological experiments on the hippocampal CA1 region, it strongly interfered with LTP induction and reduced LTP-induced persistent spine enlargement (Yamagata et al., 2009) . Furthermore, K42M reduced basal AMPA-mediated transmission (Kabakov and Lisman, 2015) , a transmission that depends on CaMKII (S. Incontro et al., 2016, Soc. Neurosci., abstract) . Such effects on basal transmission are expected of a memory molecule given the likelihood that a The platform rotates; rats learned to avoid the shock zone (red pie-shaped region), a zone with fixed relationship to the visual cues on the wall. (B) (Left) HSV-T286D/T305A/T306A-GFP was used to observe CaMKII expression. Expression was high in CA1 and the dentate 3 days after virus injection (day 10), but not 9 days after injection (day 16), in accord with known transient expression properties of HSV (Carlezon et al., 1997; Neve et al., 2005) and relatively rapid turnover of CaMKII (Cohen et al., 2013) . (Right) Similar transient expression was observed after HSV-mediated expression of GFP. On each side of the brain, injections were given at two depths at two penetration sites (STAR Methods; the target was CA1 but because injections were made at different depths, injection of dentate gyrus cells also occurred). (C) NeuN (red) staining and GFP expression (green) were used to observe the percentage of cells that were transfected, as measured 3 days after virus injection. Transfection percentage ranged from 35% to 50%. Images were taken from four animals. component of basal transmission is due to learning that occurred while the animal was alive. Thus, the reduction in basal transmission is probably due to the reversal of pre-established LTP (see evidence for this in Sanhueza et al., 2011) . Learning and memory deficits occur in animals with knockin of this mutant (Yamagata et al., 2009) . Moreover, addictive behavior could be erased by transient expression of the mutant in the accumbens (Loweth et al., 2013) . Such use of a dominant negative specifically probes CaMKII function and avoids assumptions about which of the several binding interactions of CaMKII with other proteins are involved (Robison et al., 2005; Walikonis et al., 2001) . Figure 3 shows how memory, as measured on day 16, was affected by the transient expression of dominant-negative CaMKII. On day 16, in control experiments after viral expression of GFP, memory retention was excellent (1.5 ± 0.6 shocks). In contrast, after transient expression of dominant-negative CaMKII, memory was poor (11.2 ± 4.7 shocks), statistically different from controls (n = 6, p = 0.012, D = 0.83). These results suggest that the memory of conditioned place avoidance can be substantially erased by dominant-negative CaMKII.
It might be postulated that this reduction in memory occurred because the virus damaged the hippocampus, made synapses nonfunctional, or interfered with the recall process. However, acute effects of the dominant negative on behavior are unlikely, given that the mutant CaMKII was no longer present at the time of memory tests ( Figure 1B ). Furthermore, if the mutant produced persistent effects on basic brain functions or locomotion, relearning on day 16 would be strongly compromised. In fact, relearning did occur on subsequent trials on day 16 and did so with kinetics roughly similar to that of the initial learning before virus injection ( Figure 3C ). Finally, the memory erasure produced by dominant-negative CaMKII was not due to general properties of CaMKII, as we found good memory retention on day 16 after HSV-mediated expression of wild-type (WT) CaMKII (n = 5; 3 ± 1.2 shocks; not significantly different from those seen on day 16 for HSV-GFP-injected animals [p = 0.55, D = 0.43]).
In the next series of experiments, we performed a saturation test. This test is conceptually related to that of Brun et al. (2001) . In those experiments, LTP was saturated in a significant fraction of the dorsal hippocampus after learning occurred. Because memory is encoded by a pattern of strengthened synapses (Hopfield, 1984) , large-scale saturation of synapses should interfere with memory ( Figure 2B ). Brun et al. (2001) found this to be the case. It was thus of interest to determine whether overexpression of activated CaMKII (CaMKII*; 286D/T305A/T306A) would interfere with memory. Three days after the end of training, we injected HSV that expressed CaMKII* (the triple mutant CaMKII T286D/T305A/T306A) attached to GFP (the D mutation mimics phosphorylation and produces activation; the A mutations prevent inhibitory processes; Pi et al., 2010) . Experiments in hippocampal slices showed that this form of CaMKII greatly enhances AMPA-mediated transmission and spine size (Pi et al., 2010) ; it also prevents subsequent induction of LTP, consistent with the idea that synapses are in a maximally potentiated state. Figure 4 shows that CaMKII* produced strong memory impairment on day 10, a time of HSV-mediated expression (n = 6, p = 0.02, D = 0.75). Thus, as outlined in Figure 2B , destroying the pattern of CaMKII-dependent processes in the hippocampus strongly interferes with memory. Modest relearning occurred over the three subsequent trials (trials 14-16 in Figure 4C ), perhaps due to non-transfected cells (see STAR Methods for quantification and Moser, 1998 and Rumpel et al., 2005 for evidence that behavioral effects do not require that all neurons are affected). According to the model of Chang et al. (2017) , CaMKII has no role in memory maintenance; because some other process encodes memory, that information should be retrievable despite the action of CaMKII*. The results in Figure 4 are hard to explain if memory is stored primarily by processes independent of CaMKII.
DISCUSSION
Three major tests (necessity, saturation, and erasure tests) of the role of CaMKII in the storage of a behaviorally defined memory Neurons receive synaptic inputs from many presynaptic cells (black arrows). The strength of different inputs is affected during learning; arrowhead size indicates synaptic strength. Memory is stored by the pattern of synaptic strengthening, and the persistence of these changes underlies memory storage. (A) Dominant-negative (K42M) CaMKII may erase learning-dependent changes in synaptic strength, leading to inability to recall. (B) CaMKII* (T286D/T305A/T306A) increases all weights to maximum, thereby destroying the pattern that encodes memory and preventing memory recall. Note that in experiments, the effect of CaMKII* is measured at the time of maximal expression (day 10) so as to avoid assumptions about whether the effects are acute or persistent.
have now been conducted. Previous work showed that knockout of CaMKII or expression of forms that prevent normal function strongly interferes with memory, thus satisfying the necessity test (Giese et al., 1998; Yamagata et al., 2009 ). Here we have conducted the critical erasure test that specifically probes the role of CaMKII in the memory storage process. We found that dominant-negative CaMKII, when transiently expressed for a few days after learning, produced a strong reduction in memory that persisted even when the dominant negative was no longer expressed. If the dominant negative had been present at the time of testing, the recall deficit could have been attributed to inhibition of an expression process by which the storage process enhances synaptic function. However, in our experimental design, the recall was tested at a time when HSV no longer expressed the dominant-negative CaMKII. Thus, the failure of recall cannot be attributed to a deficit in an expression process. Previous work indicated the involvement of CaMKII in the reconsolidation of memory at the time of recall (Cao et al., 2008) . Such processes are not relevant in our experiments because the dominant negative was no longer present when recall was measured. Our experiments thus suggest that dominant-negative CaMKII produced memory erasure by interfering with memory storage processes rather than expression or reconsolidation processes. Finally, erasure cannot be due to general properties of CaMKII, as erasure was not produced by viral expression of the WT form.
We have also conducted the saturation test. We found that, at the time of maximal expression of CaMKII* (day 10), memory was poorly recalled. This confirms a similar finding on the effect of global CaMKII overexpression (thus increasing CaMKII*) on fear conditioning; see Cao et al. (2008) and Wang et al. (2003) . On any simple model, such memory deficits would not be expected if processes unrelated to CaMKII stored memory, as proposed by Murakoshi et al. (2017) ; in this case, such processes could serve as a basis of memory recall even when CaMKII-dependent effects on synapses or other cellular properties (Fan et al., 2005; Labno et al., 2014; Sametsky et al., 2009) were saturated. Our work at the behavioral level is complemented by experiments on LTP showing that CaMKII satisfies the necessity (Giese et al., 1998; Hinds et al., 1998; Malinow et al., 1989; Silva et al., 1992) , saturation (Lledo et al., 1995; Pettit et al., 1994; Pi et al., 2010) , and erasure tests (Barcomb et al., 2016; Gouet et al., 2012; Sanhueza et al., 2011) . Notably, there are now three papers that have observed the erasure process and added important controls. All three papers inhibited CaMKII function in hippocampal slices using bath-applied ''CN peptide,'' a peptide that is a strongly optimized Vest et al., 2007) fragment of an endogenous inhibitory protein, CaMKIIN (Chang et al., 1998) . In the first paper (Sanhueza et al., 2011) , it was shown that 20 mM tat-conjugated CaMKIIN-derived peptide, tatCN21, when transiently applied during LTP maintenance, led to persistent erasure of LTP. Moreover, LTP could then be reinduced, indicating that the decrease of potentiation due to tatCN21 was not simply because of neuronal damage. It was further shown that treatment of hippocampal slices with tatCN21 reduced the amount of CaMKII/NMDAR complex, as measured by coimmunoprecipitation, and also decreased the amount of CaMKII in spines, as would be expected if CaMKII was released from NMDARs in the PSD. A second paper (Gouet et al., 2012) showed that the depression produced by tatCN27, another CaMKIIN-derived peptide, was not simply due to long-term depression (LTD) processes. Moreover, it was shown that erasure did not occur in neonatal animals that lack CaMKII-alpha in their PSDs. Finally, Barcomb et al. (2014) replicated the reversal of LTP by tatCN21 and demonstrated that this was a postsynaptic effect. Importantly, it was shown that effects of tatCN21 were reduced in mice with a GluN2B mutation that interfered with the ability of CaMKII to bind to NMDARs. Taken together, these results support the hypothesis that LTP maintenance depends on CaMKII and that this involves the structural interaction of CaMKII with the NMDAR. The fact that interference with CaM-KII can erase both LTP and memory provides support for the hypothesis that LTP contributes to memory storage (Bliss and Collingridge, 1993; Morris et al., 2003) .
Several other hypotheses regarding the molecular basis of memory have been put forward (Hayashi-Takagi et al., 2015; Si and Kandel, 2016; Tsokas et al., 2016) . For instance, memory erasure was achieved using transient application of the PKMzeta inhibitor, ZIP (Pastalkova et al., 2006) . However, subsequent findings revealed the non-specificity and toxicity of ZIP, making these experiments difficult to interpret (Lee et al., 2013; Sadeh et al., 2015; Volk et al., 2013) . More recent experiments (Shema et al., 2011; Tsokas et al., 2016) employing better PKM-zeta inhibitors have used persistent rather than transient application methods. Using transient application is critical for interpretation: if recall becomes possible after removal of inhibitor, an expression process was affected; if recall does not recover, a storage mechanism was affected. Because these possibilities were not resolved, further work will be required to specifically demonstrate a role of PKM-zeta in the memory storage process.
Evidence against the Role of CaMKII in LTP and Memory Maintenance
A recent model posits that the only role of CaMKII is during the minute period during and after LTP induction (Chang et al., 2017) . During this period, autophosphorylation of CaMKII integrates the Ca 2+ signal (Lee et al., 2009 ) (but see Otmakhov et al., 2015) . A key finding was that a photo-activatable CaMKII inhibitor, AIP2, could block LTP induction when activated during the first minute after induction but had no effect if activated during subsequent periods (Murakoshi et al., 2017) . This work provides impressive data about the duration of the AIP-sensitive period and is consistent with previous work showing that several types of CaMKII inhibitor can interfere with LTP induction, but not LTP maintenance (Chen et al., 2001; Malinow et al., 1989; Tsien et al., 1990 ). However, as described above, an important and now replicated finding is that another class of CaMKII inhibitor (CN type) does interfere with LTP maintenance (Barcomb et al., 2016; Sanhueza et al., 2011) .
Is there an explanation of this difference? We suggest that these results can be reconciled using a model in which there is a mechanistic distinction between the early stages of LTP near the time of induction and later maintenance phases. The general proposition that there are different phases of LTP is widely accepted on multiple grounds (Bosch et al., 2014; Frey et al., 1993; Huang and Kandel, 1994; Meyer et al., 2014; Redondo et al., 2010) . We suggest that the potentiation triggered within the first minute after LTP induction depends on phosphorylation of substrates by CaMKII* (e.g., synGAP [Araki et al., 2015] or TARP [Tomita et al., 2005] ) ( Figure 5 ). In contrast, later stages of LTP that underlie LTP maintenance depend more critically on the structural processes that occur when CaMKII binds to the NMDAR or other PSD proteins (Sanhueza and Lisman, 2013) . The evidence suggests that these different types of CaMKII action have different dependencies on CaMKII inhibitors. In support of this proposition, 5 mM tatCN21 was found to block LTP induction, but did not affect LTP maintenance (Buard et al., 2010) or the amount of CaMKII/NMDAR complex (Sanhueza et al., 2011; Vest et al., 2007) ; in contrast, LTP maintenance and the amount of complex were reduced by 20 mM tatCN21 (Sanhueza et al., 2011; Vest et al., 2007) . Thus, the concentration of peptides and their affinity for CaMKII are important parameters to consider. The experiments of Murakoshi et al. (2017) used the inhibitor AIP2, which has an IC 50 for CaMKII that is at least an order of magnitude higher (i.e., lower potency) than that of tatCN21 Ishida et al., 1998) . Thus, a simple explanation of the failure of AIP2 to affect LTP maintenance (Murakoshi et al., 2017) is that the inhibitor's concentration was sufficient to prevent CaMKII phosphorylation of substrates, but not sufficient to interfere with the binding of CaMKII to the NMDAR.
With regard to this interpretation, an experiment reported by Murakoshi et al. (2017) requires further discussion. It was claimed that AIP2 does in fact prevent the binding of CaMKII to the NMDAR, but there are technical concerns about how the experiment was conducted. Ca 2+ was used to generate phosphorylated CaMKII; because AIP2 was present during that phosphorylation procedure and would be expected to block it, and because multi-site binding of CaMKII to NMDARs depends on CaMKII phosphorylation (Bayer et al., 2001) , the effect of AIP2 on binding may not have been direct but, rather, due to the failure to generate phosphorylated CaMKII.
Finally, Chang et al. (2017) and Murakoshi et al. (2017) , in support of their model, refer to the persistence of LTP maintenance in the T286A CaMKII-alpha mutant, a mutant that prevents persistent activation of CaMKII. However, the study only follow maintenance for short periods. Other work using the same mutation (Villers et al., 2014) measured LTP over longer periods and found that normal LTP was not maintained but, rather, was replaced by a form of potentiation that does not have synapse specificity or NMDAR dependence. In summary, the model of Chang et al. (2017) and Murakoshi et al. (2017) leaves a large number of experimental results demonstrating long-lasting changes in CaMKII unexplained (Ahmed and Frey, 2005; Fukunaga et al., 1993; Lengyel et al., 2004; Otmakhov et al., 2004) and is inconsistent with results showing that manipulations of CaMKII during the maintenance period can affect LTP (Barcomb et al., 2016; Sanhueza et al., 2011) and behavior (Figures 3   and 4) . With regard to behavior, the effect of T286A mutation on long-term memory is also relevant. Under standard training conditions, this mutant produces devastating effects on longterm memory (Giese et al., 1998) , but with extended training, one form of long-term memory can survive (Irvine et al., 2005) . This finding cannot be used to exclude a requirement for CaMKII in long-term memory because there is a substantial amount of a second CaMKII isoform, CaMKII-beta, that can contribute to synaptic function (Groth et al., 2011; Hinds et al., 1998 ; (A) Path of rats (gray; superposition of six experiments) on circular platform before and after injection of control virus expressing GFP; shock zone (red pie shape) and individual shocks given (small red circles). Trial 1 is first training trial on day 1, trial 12 is last training trial (on day 4), and reduction in number of shocks indicates learning. Trial 13 tests memory retention on day 10, 3 days after viral injection. Trials 14-16 show a deficit in relearning on day 10. (B) Path of rats before and after injection of virus expressing CaMKII* (T286D/T305A/T306A). (C) Summary data. After viral expression of T286D/T305A/T306A, memory was poor (p = 0.02, D = 0.75) (n = 6) compared to GFP controls. After viral expression of GFP, memory was strong in one group measured at day 10 (n = 2) and in another group measured at day 16 (n = 6) (the groups are not significantly different, so data are combined here as ''day 10''; n = 8). For CaMKII*-injected animals, memory on day 10 was not significantly different than memory on day 16 for K42M-injected animals (p = 0.8096, D = 0.3333). A two-sample Kolmogorov-Smirnov test was used to determine statistical significance. Error bars represent mean ± SEM. Asterisks indicate statistical significance (p < 0.05; Kolmogorov-Smirnov test).
S. Incontro et al., 2016, Soc. Neurosci., abstract) and behavior (Borgesius et al., 2011) after knockout of the alpha isoform.
CaMKII as a Memory Molecule: Basis of Stability
The idea that CaMKII mediates memory storage is supported by structural and biochemical properties of CaMKII that suggest a simple molecular mechanism ( Figure 5 ) by which information can be stably stored by CaMKII holoenzymes (Lisman, 1985; Miller et al., 2005) . It is envisioned that the activated (phosphorylated) state of CaMKII forms the ''on'' state of a memory switch. Although the rate of T286 dephosphorylation within the PSD is very slow (Mullasseril et al., 2007) , it must occur at some finite rate. However, when this occurs, a stable level of CaMKII phosphorylation can nevertheless be achieved because the site can be re-phosphorylated by a nearby active subunit (note that the slow measured dephosphorylation explains why brief inhibition of CaMKII-dependent autophosphorylation has little effect; Murakoshi et al., 2017; Otmakhov et al., 1997) . It has further been proposed that the CaMKII switch can retain its ''on'' state despite protein turnover; stability could be achieved if turnover occurred by subunit exchange (Lisman, 1985; Miller et al., 2005) . In this case, a newly inserted unphosphorylated subunit could be re-phosphorylated by an active neighboring subunit (Rich and Schulman, 1998) . Recent experiments provide direct support for subunit exchange in CaMKII (Stratton et al., 2014 ).
In the model of Figure 5 , information is stored because a dynamic process maintains the level of phosphorylated CaMKII. The plausibility of this dynamic process was tested in reconstitution experiments using purified proteins (Urakubo et al., 2014) . It was shown that a simple chemical system containing CaMKII, calmodulin, protein-phosphatase 1, and a peptide fragment containing the CaMKII-binding site on the NMDA channel could function as a switch. The ''on'' state of the switch (CaMKII*), as defined by high phosphorylation of T286, could be turned on by a brief pulse of calcium. It was shown that this ''on'' state persisted for many hours, sustained by a dynamic process in which dephosphorylated subunits were rephosphorylated by nearby active subunits, as postulated in Figure 5 .
Caveats
Although our behavioral experiments are powerful probes of memory function, several caveats should be noted. First, it is formally impossible to prove memory erasure because what is measured is recall, making it possible that what is compromised is recall rather than storage. However, the fact that the K42M mutant was no longer present at the time of recall and the observation that subsequent recall of newly learned information was reasonably normal ( Figure 3C ) argues against this possibility. Second, it is possible that CaMKII is not the storage molecule itself but somehow resets (or disabled for many days) another molecule that is actually responsible for storage. Although this possibility cannot be excluded, it is unparsimonious, given the evidence that CaMKII has the structural and biochemical properties required to store information ( Figure 5 ). Finally, we emphasize that memory storage by CaMKII is probably not due to the bulk CaMKII in the cytoplasm but, rather, to the small pool of CaMKII within the PSD ( Figure 5 ) (Feng et al., 2011) . Although the CaMKII in the PSD is in part bound to GluN2B, a pool important for LTP induction (Barria and Malinow, 2005) , CaMKII can also bind to GluN1 and other PSD proteins (Leonard et al., 2002; Robison et al., 2005) . Some of these interactions, notably that with densin (Jiao et al., 2011) , can be affected by CN peptides. The existence of multiple PSD binding partners of CaMKII may explain why a knockin of a GluN2B mutation that reduces CaMKII binding had only modest effects on memory (Stein et al., 2014) . Further analysis of the CaMKII interactome will be necessary to fully specify the CaMKII complex within the PSD that mediates memory storage.
Concluding Comments
The brain is likely to have multiple mechanisms for memory storage, only one of which may be CaMKII dependent. Indeed, there is now evidence for epigenetic and transcriptional regulatory processes that control learning-dependent changes, including global changes in cellular excitability (Abel and Klann, 2013; Meadows et al., 2016; Yiu et al., 2014; Zhou et al., 2009) . Thus, both cell-wide and synapse-specific processes may be necessary for memory storage. Holoenzymes contain 12 catalytic subunits, but only 4 are shown for simplicity. During LTP induction, CaMKII-alpha becomes persistently activated (Miller and Kennedy, 1986; Saitoh and Schwartz, 1985) by phosphorylation at T286. CaMKII* translocates to the postsynaptic density (PSD), where it binds to NMDARs. During the first minute after induction, CaMKII* produces potentiation of synaptic transmission by a phosphorylation-dependent process, leading to addition of AMPARs to the synapse without changing its size (Barria and Malinow, 2005; Bayer et al., 2001; Strack and Colbran, 1998) . Maintenance of later phases of LTP can be reversed by interference with a structural process that involves the binding of CaMKII to NMDAR (Barcomb et al., 2016; Sanhueza et al., 2011) , and results in enlargement of the synapse (Bosch et al., 2014; Meyer et al., 2014) . According to computational models (Lisman, 1985; Miller et al., 2005) , information is stored by stable changes in the number of CaMKII bistable switches in the ''on'' state. The ''on'' (phosphorylated) state (CaMKII*) in the PSD is stable because intersubunit autophosphorylation leads to T286 phosphorylation (and activation) of new subunits that are incorporated into the holoenzyme due to subunit exchange and to rephosphorylation of T286 sites that are dephosphorylated by phosphatase (phosphatase is present in the PSD and can rapidly dephosphorylate some sites on CaMKII, but dephosphorylates T286 very slowly; Mullasseril et al., 2007) .
The evidence that CaMKII can serve as a molecular memory now opens the door to addressing the relationship of CaMKII to other major problems in memory research. Recent work shows that late LTP involves trans-synaptic enlargement of synapses (Bosch et al., 2014; Meyer et al., 2014) . Thus, a key question for future investigation is to understand how CaMKII could organize this enlargement (for several possibilities, see Lisman and Raghavachari, 2015) . Furthermore, the elucidation of the fundamental role of CaMKII in memory may serve as a foundation for understanding memory and psychiatric problems in which dysregulation of CaMKII has been observed (Ghosh and Giese, 2015; Robison, 2014) .
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was measured in three 10-minute trials after the retention trial for both the erasure and saturation tests. All behavioral experiments were done blind.
Viral Injection
HSV injection was performed on day 7 for both erasure and saturation tests. Animals (300-500 g at time of surgery) were anesthetized with a combination of ketamine (100 mg/kg, ip) and xylazine (2.5 mg/kg, ip) and were placed in a stereotaxic apparatus (Kopf Instruments). Injections of the virus were bilateral (AP: À3.5, ML: ± 2.0, DV: À2.7 (and À3.0) and AP: À5.3 ML: ± 2.6 DV:-2.2 (and À2.5)), with the primary target being the CA1 region of the hippocampus. A total of eight injections were made at four injection sites, with two injections of different depths at each site, often leading to the deepest injection producing expression in the dentate gyrus ( Figure 1B) . Each injection (Nanoject II) consisted of fourteen 50 nL volumes of virus with 6 s between each volume. Overall for each injection, 0.7 uL of the virus was injected over the course of 1.5 minutes. After each injection, the glass pipette was left in place for 5 minutes in order to facilitate diffusion of the virus. All surgery was conducted with aseptic technique.
HSV vector HSV viral vectors with inserted genes (GFP, mutant CaMKII, WT) were obtained from Rachael Neve at the MIT Viral Core Facility. Expression of the T286D/T305A/T306A mutant CaMKII gene (fused with GFP) and WT CaMKII (fused with GFP) were controlled by the HSV IE 4/5 promoter. Expression of the K42M mutant CaMKII gene was similarly controlled by the HSV IE 4/5 promoter, with GFP expression being separately controlled by the CMV promoter, a viral construct used in prior work (Loweth et al., 2013) . For the virus only expressing GFP, no target gene was inserted into the vector and GFP expression was driven by the CMV promoter.
Immunohistochemistry
To measure viral expression, 3 days after virus injection (saturation) and 9 days after virus injection (erasure), intracardial perfusion was performed and brains were fixed in a 4% paraformaldehyde solution. After a day in 4% formaldehyde, brains were placed in a 0.1M PBS solution for a day before being sectioned. Hippocampal slices of the CA1 region were obtained using a vibrating blade microtome Leica VT1000 S (Leica Microsystems). For HSV-T286D/T305A/T306A, the expression of CaMKII could be directly measured via immunostaining because the construct being expressed consisted of GFP directly attached to CaMKII (CaMKII-GFP). For HSV-K42M, the CaMKII protein and GFP are separately expressed by the same virus. As a result, immunostaining only allowed for direct visualization of GFP, which may or may not reflect the continued presence of CaMKII. 1:5000 chicken anti-GFP (Aves Labs) primary antibodies and 1:500 goat anti-chicken alexa 488 (Thermo Fisher Scientific) secondary antibodies were used to enhance fluorescence of GFP. By comparing GFP fluorescence with NeuN staining, we could estimate the fraction of transfected neurons in regions near the injection sites ($1 mm). For the NeuN staining, 1:1000 mouse anti-NeuN (EMD Millipore) were used as the primary antibodies with 1:500 goat anti-mouse alexa 594 (Thermo Fisher Scientific) as the secondary antibodies. For both staining procedures, slices were mounted with DAPI-mounting medium (Vector Laboratories) in order to stain the cell bodies. 35%-50% of neurons were found to transfected ( Figure 1C ) With multiple injection sites, inhomogeneity of transfection is inevitable; however, such inhomogeneity and even low transfection levels do not preclude meaningful and reproducible effects (Moser and Moser, 1998; Rumpel et al., 2005) . To verify the injection sites after the retention test (9 days after virus injection when GFP is no longer expressed), sterile 0.5 mm red fluorescent beads (Molecular Probes) were co-injected. Beads were excited at 580 nm. In a small fraction of experiments, beads could not be detected in sections and these experiments were eliminated from consideration. Fluorescent images were captured using a Keyence Fluorescence Microscope and were analyzed with the Fiji ImageJ image-processing software.
QUANTIFICATION AND STATISTICAL ANALYSIS
A two-sample Kolmogorov-Smirnov test was used to determine whether distributions were statistically different for behavioral data. The p value is given, as well as D, the maximum difference between the two cumulative fraction plots of the tested samples. All statistical analysis was done in MATLAB (MathWorks). All data is shown as mean ± standard error (SEM). n indicates the number of animals used for each behavioral experiment.
